NDAORALTABLET
Approved
May 2006
Lifecycle
LOE Approaching
Competitive Pressure
15/100
Clinical Trials
3
Data completeness
5/8 — Partial
SEASONIQUE (levonorgestrel / ethinyl estradiol and ethinyl estradiol) by Teva is ovulation. First approved in 2006.
Drug data last refreshed 18h ago · AI intelligence enriched 2w ago
AI summarySynthesized from FDA + DailyMed + ClinicalTrials.gov data
SEASONIQUE is an oral contraceptive containing levonorgestrel and ethinyl estradiol, designed to prevent ovulation and provide pregnancy prevention. It is a combination hormonal contraceptive tablet taken orally, marketed as an extended-cycle formulation to reduce menstrual frequency. The product targets women seeking reliable contraception with reduced bleeding episodes compared to traditional monthly cycles.
$0.1MPart D
LOE Approaching2.6 years to LOEProduct approaching loss of exclusivity with minimal Part D claims, indicating a mature market with limited commercial growth opportunity and likely stable, lean team structure.
Mechanism of Action
ovulation.
Indications
Indication data is being enriched from DailyMed and FDA labeling. Check back soon for approved therapeutic uses.
Clinical Trials (3)
A Study to Evaluate the Efficacy of Seasonique for the Treatment of Cyclic Pelvic Pain
Started May 2005
95 enrolled
Dysmenorrhea
A Study to Evaluate the Efficacy of Seasonique for the Treatment of Cyclic Pelvic Pain
Started Jan 2005
97 enrolled
Dysmenorrhea
A Multicenter Study to Evaluate the Safety of Seasonique, an Oral Contraceptive.
Started May 2003
320 enrolled
Contraception
Why This Matters for Your Career
Worked on SEASONIQUE at Teva? Share your interview experience or compensation data (+7 days Pro)
Data Sources
- Drug label: DailyMed / FDA
- Clinical trials: ClinicalTrials.gov
- Patent data: FDA Orange Book
- Spending data: CMS Medicare
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.